Infection control: Need for robust guidelines

Similar documents
Infektionshygiejne i en tid med multiresistente bakterier

Carbapenemase-Producing Enterobacteriaceae (CPE)

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S

LA-MRSA in the Netherlands: the past, presence and future.

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Other Enterobacteriaceae

(DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE

Multi-Drug Resistant Organisms (MDRO)

Presenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update

Multi-drug resistant microorganisms

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection.

DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

MRSA CROSS INFECTION RISK: IS YOUR PRACTICE CLEAN ENOUGH?

Randall Singer, DVM, MPVM, PhD

Is biocide resistance already a clinical problem?

Hospital Infection. Mongolia, October Walter Popp Hospital Hygiene University Clinics Essen, Germany

Antimicrobial Resistance and Papua New Guinea WHY is it important? HOW has the problem arisen? WHAT can we do?

Glycopeptide Resistant Enterococci (GRE) Policy IC/292/10

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Hospital ID: 831. Bourguiba Hospital. Tertiary hospital

Infection Control of Emerging Diseases

Antimicrobial Cycling. Donald E Low University of Toronto

Version Control Sheet

Escalating Problem on Pseudomonas and Acinobacter Resistance and MDRO

MRSA in the United Kingdom status quo and future developments

Infection Prevention and Control Policy

DANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme

Origins of Resistance and Resistance Transfer: Food-Producing Animals.

Two (II) Upon signature

Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

Hosted by Dr. Jon Otter, Guys & St. Thomas Hospital, King s College, London A Webber Training Teleclass 1

Initiatives taken to reduce antimicrobial resistance in DK and in the EU in the health care sector

MRSA What We Need to Know Sharon Pearce, CRNA, MSN Carolina Anesthesia Associates

So Why All the Fuss About Hand Hygiene?

EFSA s activities on antimicrobial resistance in the food chain: risk assessment, data collection and risk communication.

Birgit Ross Hospital Hygiene University Hospital Essen Essen, Germany. Should we screen for multiresistant gramnegative Bacteria?

Fighting MDR Pathogens in the ICU

MRSA Control : Belgian policy

Advice for those affected by MRSA outside of hospital If you have MRSA this booklet provides information to help manage your day-to-day life

Microbiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:

Overview of Infection Control and Prevention

Antimicrobial Resistance: Do we know everything? Dr. Sid Thakur Assistant Professor Swine Health & Production CVM, NCSU

Testimony of the Natural Resources Defense Council on Senate Bill 785

Infection Control and Standard Precautions

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Animal Antibiotic Use and Public Health

Infection Prevention & Control in Ambulatory Surgical Centers. Objectives

MDRO: Prevention in 7 Steps. Jeanette Harris MS, MSM, MT(ASCP), CIC MultiCare Health System Tacoma, Wa.

Proceedings of. The 15 th Chulalongkorn University Veterinary Conference CUVC 2016: Research in Practice. April 20-22, 2016 Bangkok, Thailand

Infectious Disease in PA/LTC an Update. Karyn P. Leible, MD, CMD, FACP October 2015

2 nd UK-Russia Round Table on AMR. Christopher Teale, Animal and Plant Health Agency. Moscow, st February 2017.

EFSA s activities on Antimicrobial Resistance

EFSA s activities on Antimicrobial resistance in the food chain. Dr. Ernesto Liebana Head of BIOCONTAM Unit. EFSA

Overview of C. difficile infections. Kurt B. Stevenson, MD MPH Professor Division of Infectious Diseases

Horizontal vs Vertical Infection Control Strategies

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Carbapenemase-Producing Enterobacteriaceae Multi Drug Resistant Organism Management Procedure. (IPC Manual)

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance


Dissecting the epidemiology of resistant Enterobacteriaceae and non-fermenters

Advice for those affected by MRSA outside of hospital

Antimicrobial Resistance

Clostridium difficile Infection Prevention. Basics of Infection Prevention 2-Day Mini-Course 2012

Clostridium Difficile Primer: Disease, Risk, & Mitigation

18/08/2016. Safe Patient Care. Keeping our Residents Safe. Background. Infection Prevention and Control developing over the last 40 years

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

Today s Agenda: 9/30/14

Surveillance cultures: Can they help our decisions

28/08/2017. Infection Prevention and Control. Safe Patient Care Bugs and Drugs The ongoing challenge of MDROs and AMR

Lindsay E. Nicolle University of Manitoba Winnipeg, CANADA

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

The role of Infection Control Nurse in Prevention of Surgical Site Infection (SSI) April 2013

Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

A patient s guide to. MRSA - Methicillin Resistant Staphylococcus Aureus

WHY IS THIS IMPORTANT?

Prevalence & Risk Factors For MRSA. For Vets

Antimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD

TABLE OF CONTENTS. 1. Purpose of the WRHA Infection Prevention and Control Manual 2.1 and approval process

Surgical prophylaxis for Gram +ve & Gram ve infection

Questions and answers about methicillin-resistant Staphylococcus aureus (MRSA)

Actions for combatting Antimicrobial Resistance (AMR)

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

How is Ireland performing on antibiotic prescribing?

EC Workshop on scientific advice from AMEG

Antimicrobial resistance I: Situation and strategies in Europe

Infection Prevention & Control: PPE and Beyond. Stacy Martin, RN, BSN, CIC Manager, Infection Prevention & Control

Nosocomial Infections: What Are the Unmet Needs

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 2 Understanding the spread

Policy Forum. Environmental and Professional Hygiene: Toward the Prevention of Drug Resistant Infections

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

Summary COMITÉ SUR LES INFECTIONS NOSOCOMIALES DU QUÉBEC. February 2018

Transcription:

Infection control: Need for robust guidelines Hans Jørn Kolmos MD DMSc Professor, consultant Department of Clinical Microbiology Odense University Hospital hans.joern.kolmos@ouh.regionsyddanmark.dk Combating carbapenemase and ESBL-producing Gram-negative bacteria DTU 160312

Setting the scene What is the problem? Underlying factors? Routes of transmission? Prevalence of the problem? How to deal with the problem? Prevention? Control?

Selection and transmission of resistance Transmission by humancontact & food (E. coli) (Klebsiella) Selection with antibiotics

We are what we eat: ESBL genes in enterobacteria from chicken meat and humans in the same geographic ares Chicken meat 80% Human rectal swabs 5% Overdevest et al. Emerg Infect Dis 2011;17:1216-22

ESBL: The steps from contamination to infection Many Some Few Patient with invasive infection Intestinal colonization (low conc) Selection of ESBL (high conc) Destruction of normal intestinal flora by antibiotics Breach of natural barriers (surgery, catheters, chemotherapy etc) Healthy individual Acquisition of ESBL by human contact & food

Consumption of tetracyclines in pigs and humans Pigs Pts prim health care DANMAP 2010

Tetracycline-resistance in ESBL-E. coli & MRSA from farm animals ESBL E. coli (broilers & pigs) 89-97 % MRSA CC398 (pigs) 95 % Costa et al. Vet Microbiol 2009; 138: 339-44 Ho et al. JAC 2011; 66: 765-8 DANMAP 2008

Coupling of resistance characters on plasmids: the genetic background for co-selektion R kobber R zink R tetra R ampi R ceph R genta

High-priority actions in reducing antibiotic prescribing Tetracyclines (Fluoroquinolones) (Cephalosporins) Fluoroquinolones Tetracyclines Fluoroquinolones Cephalosporins

Infection control: The foundation is general precautions ESBL & CPE Other emerging MRSA C. diff Noro General precautions

General precautions Hand hygiene Targeted use of gloves & aprons Face protection, if relevant Spot disinfection of spills Disinfection/sterilization of utensils & equipment Proper domestic cleaning Safe reprocessing of laundry Safe handling of human secretions & waste.boring, but essential

Specific precautions: search, contain, and destroy Screening for ESBL & CPE Isolation of patients tested positive Eradication of ESBL & CPE carriage Follow-up & control.fancy, but probably not feasible

Screening for ESBL on admission? MRSA ESBL Expected strain prevalence Well-defined risk groups Eradication possible 1-2 % 5-10 % Yes? Yes?

Candidates for single-room isolation General precautions Single-room isolation ESBL only yes no E. coli ESBL + cip- & genta-r Klebsiella ESBL + cip- & genta-r CPE (VIM,NDM-1, KPC-2,oxa-48 etc.) yes yes yes no yes yes

No effect of single room isolation on MRSA Compliance with hand hygiene: 21 % Cepeda et al Lancet 2005; 365: 295-304

Compliance decreased with the complexity of isolation regimes Contact precautions Contact-droplet precautions P Overall compliance 50 % 40 % 0.05 Frequency of hand washing 63 % 46 % 0.0007 Evans et al. Surgery 2003; 134: 180-8

Single room isolation: lower contact time with staff more adverse events Adverse events No/1000 days Isolated Controls P Preventable 20 3 <0.001 Non-preventable 11 12 0.98 Stelfox et al. JAMA 2003;290:1899-905

our practice of contact isolation may indeed work not through preventing contact transmission, but by preventing contact with the isolated patient alltogether Evans et al. Surgery 2003; 134: 180-8

The five moments for hand hygiene: Do the clinicians really understand? Courtesy: WHO

Effectiveness of hand hygiene (antiseptic hand rubs) Pittet et al. Lancet 2000; 356: 1307-12

Kolmos et al. J Hosp Infect 2006;64(Suppl 1): S54 Antiseptic hand rub: Progress but with room for improvement 33% 46% 21% Rubbing defects Correct procedure Insufficient amount

Conclusions Important measures to control ESBL (& CPE): Reducing selection by antibiotic restriction Health care Food production Hygienic measures against transmission by contact Focus on general precautions Particularly hand hygiene & safe handling of food Single room isolation in selected cases Key principle: Keep it simple!